 BURLINGAME, Calif., April 29, 2021 GLOBE NEWSWIRE -- Corvus Pharmaceuticals, Inc. Nasdaq: CRVS, a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the first quarter ended March 31, 2021. 